NKGen Biotech Inc. Common... (NKGN)

NASDAQ: NKGN · Real-Time Price · USD

0.17

0.02 (13.33%)

At close: Apr 29, 2025, 3:56 PM

NKGen Biotech Common Stock Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3K	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	326K	300K	300K	n/a	n/a	15K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	-326K	-300K	-300K	n/a	n/a	-15K	3K	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-6.79M	-7.46M	-7.62M	-9.43M	-6.9M	-2.68M	-954.84K	-635.12K	-404.05K	-968.96K	-731.91K	-1.41M	-804.04K	-262.39K	-35.67K
Interest Income	n/a	n/a	n/a	n/a	n/a	1.42M	1.97M	1.33M	904.52K	124.76K	44.03K	19.73K	21.28K	136.00	n/a
Pretax Income	6.6M	-16.09M	-5.38M	-33.6M	-33.18M	-1.54M	782.87K	-2.75M	1.07M	4.67M	2M	-1.34M	4.69M	-4.31M	-35.67K
Net Income	6.6M	-16.09M	-5.38M	-33.61M	-33.18M	-1.83M	378.88K	-3.02M	887.57K	4.68M	2M	-1.34M	4.69M	-4.31M	-35.67K
Selling & General & Admin	4.01M	4.37M	4.35M	5.34M	2.97M	2.63M	904.84K	613.92K	354.19K	919.64K	683.14K	1.35M	737.22K	229.54K	1.65K
Research & Development	2.78M	3.09M	2.94M	3.79M	3.93M	n/a	3.6M	4.09M	4.12M	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	n/a	n/a	-497K	n/a	1.74M	-50K	-50K	-21.2K	-49.86K	-49.32K	-48.77K	-51.51K	-66.82K	-32.85K	-34.02K
Operating Expenses	6.79M	7.46M	7.29M	9.13M	6.9M	2.68M	954.84K	635.12K	404.05K	968.96K	731.91K	1.41M	804.04K	262.39K	35.67K
Interest Expense	472K	647K	1.07M	438K	211K	62K	34K	616K	636K	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	-31K	n/a	n/a	n/a	-2.29M	-1.54M	-1.52M	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	6.79M	7.46M	7.62M	9.43M	6.9M	2.68M	954.84K	635.11K	404.06K	968.95K	731.91K	1.41M	804.05K	262.39K	35.67K
Income Tax Expense	n/a	n/a	282.72K	7K	-89K	286.78K	403.99K	274.3K	179.48K	-15.4K	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	29.13M	24.17M	21.94M	21.89M	13.4M	16.83M	21.45M	21.45M	21.45M	21.45M	21.45M	21.45M	21.45M	21.45M	21.45M
Shares Outstanding (Diluted)	41.33M	24.17M	21.94M	21.89M	13.4M	16.83M	21.45M	21.45M	21.45M	21.45M	21.45M	21.45M	21.45M	21.45M	21.45M
EPS (Basic)	0.22	-0.67	-0.25	-1.54	-2.48	-0.11	0.02	-0.14	0.04	0.22	0.09	-0.06	0.22	-0.2	-0.00
EPS (Diluted)	0.15	-0.67	-0.25	-1.54	-2.48	-0.11	0.02	-0.14	0.04	0.22	0.09	-0.06	0.22	-0.2	-0.00
EBITDA	7.4M	-15.12M	-3.99M	-32.86M	-32.67M	-2.68M	-954.84K	-5.58M	-6.06M	-968.96K	-731.91K	-1.41M	-804.04K	-262.39K	-35.67K
EBIT	7.07M	-15.44M	-4.31M	-33.16M	-32.97M	-7.79M	-8.29M	-6.33M	-6.06M	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	332K	326K	326K	300K	300K	122.08K	304K	746K	27.08K	86.06K	n/a	n/a	n/a	n/a	n/a